Angelman Syndrome Clinical Trials
2 recruiting trials for Angelman Syndrome. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Angelman Syndrome clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Rush University Medical Center (1), Institut National de la Santé Et de la Recherche Médicale, France (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Functional Behavioral Training (FBT) (behavioral, 1 trial), followed by Positive Parenting Strategies-Treatment as Usual.
Track Angelman Syndrome trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
The purpose of this study is to evaluate the effectiveness of an adapted, telehealth functional behavioral therapy (FBTsIDD) specifically focused on promoting appropriate...
IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
The goal of this observational study is to describe the natural history of imprinting disorders (IDs) according to their metabolic profile in all patients (adults and children)...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Angelman Syndrome, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Angelman Syndrome, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Angelman Syndrome, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.